Pain Relief Tablet Franchise in Ahmedabad

Ortho Medicine Supplier in Mumbai

Pain Management Tablet Distributor in Delhi

Etoricoxib Tablet Manufacturer in Bangalore

Muscle Relaxant Tablet Stockist in Hyderabad
Pain Relief Tablet Exporter in Chandigarh

Home/Products /etoricoxib-60mg-thiocolchicoside-4mg-paracetamol-325mg-tablet

Etoscrib Plus Tablet

Composition : Etoricoxib (60mg) +Thiocolchicoside (4mg) + Paracetamol (325mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Etoscrib Plus Tablet containing Etoricoxib, Thiocolchicoside, and Paracetamol is used for the management of pain and muscle spasm. It helps in reducing inflammation, relieving pain, and improving mobility in musculoskeletal conditions.

Etoricoxib acts as an anti-inflammatory agent to reduce pain and swelling, Thiocolchicoside works as a muscle relaxant to relieve stiffness and spasms, and Paracetamol provides additional analgesic support for effective pain control.

The tablet is widely prescribed in orthopedic and general practice for conditions like back pain, joint pain, and muscle stiffness, leading to high demand and consistent repeat prescriptions.

With increasing cases of lifestyle-related pain and orthopedic issues, this product offers excellent business potential for retailers and distributors. Its fast relief profile, high prescription rate, and strong market demand make it a fast-moving product that can drive consistent sales and growth in the pain management segment.

Read More

About the Product

Etoscrib Plus Tablet containing Etoricoxib, Thiocolchicoside, and Paracetamol is used for the management of pain and muscle spasm. It helps in reducing inflammation, relieving pain, and improving mobility in musculoskeletal conditions.

Etoricoxib acts as an anti-inflammatory agent to reduce pain and swelling, Thiocolchicoside works as a muscle relaxant to relieve stiffness and spasms, and Paracetamol provides additional analgesic support for effective pain control.

The tablet is widely prescribed in orthopedic and general practice for conditions like back pain, joint pain, and muscle stiffness, leading to high demand and consistent repeat prescriptions.

With increasing cases of lifestyle-related pain and orthopedic issues, this product offers excellent business potential for retailers and distributors. Its fast relief profile, high prescription rate, and strong market demand make it a fast-moving product that can drive consistent sales and growth in the pain management segment.

Some patients may experience nausea, gastritis, dizziness, headache, or drowsiness. Rarely, serious side effects such as gastrointestinal irritation, liver enzyme elevation, or allergic reactions may occur and require medical attention.

Etoscrib Plus Tablet is indicated for the management of acute musculoskeletal pain, muscle spasms, low back pain, cervical pain, and conditions like osteoarthritis or spondylitis. It helps reduce inflammation, relieve muscle stiffness, and alleviate pain, thereby improving movement and daily functioning.

This medicine should be taken under medical supervision. Patients with a history of heart disease, gastrointestinal issues, liver disorders, or those taking other medications should consult their healthcare provider before use. Avoid alcohol consumption and do not exceed the recommended dose.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation